CASSETTE BACULOVIRUS VECTORS FOR THE PRODUCTION OF CHIMERIC, HUMANIZED, OR HUMAN-ANTIBODIES IN INSECT CELLS

被引:26
作者
POUL, MA
CERUTTI, M
CHAABIHI, H
TICCHIONI, M
DERAMOUDT, FX
BERNARD, A
DEVAUCHELLE, G
KACZOREK, M
LEFRANC, MP
机构
[1] UNIV MONTPELLIER 1,INST MOLEC GENET,IMMUNOGENET MOLEC LAB,CNRS,UMR 9942,F-34033 MONTPELLIER,FRANCE
[2] UNIV MONTPELLIER 2,INST MOLEC GENET,IMMUNOGENET MOLEC LAB,CNRS,UMR 9942,F-34033 MONTPELLIER,FRANCE
[3] INRA,ST CHRISTOL ALES,FRANCE
[4] PROT PERFORMANCE,ST CHRISTOL ALES,FRANCE
[5] INSERM,U343,NICE,FRANCE
关键词
ENGINEERED ANTIBODY; IMMUNOGLOBULIN; BACULOVIRUS; INSECT CELLS; CHIMERIC ANTIBODY;
D O I
10.1002/eji.1830250731
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmid cassette-transfer vectors pBHuC kappa, and pBHuC gamma 1 have been designed which enable the construction of recombinant baculoviruses directing the coexpression of complete immunoglobulin in insect cells. We describe the application of these vectors for the expression of a human/mouse chimeric monoclonal antibody of potential immunosuppressive clinical value derived from a mouse anti-human CD29 monoclonal antibody (Mu-K20). The chimeric K20 light and heavy chains produced in sf9 insect cells were correctly processed and assembled into a normal immunoglobulin which is secreted into the culture medium of infected cells. The chimeric mAb Ch-K20-sf9 reproduces in vitro the functional properties of the parental mouse K20: including affinity and inhibition of lymphocyte proliferation. These results demonstrate that the baculovirus/insect cell expression system is suitable for the expression of fully active monoclonal antibodies of therapeutic value. Our generic cassette approach makes this system a very flexible and convenient one for the rapid production of either chimeric, humanized or human mAb with heavy and light chains of any isotype.
引用
收藏
页码:2005 / 2009
页数:5
相关论文
共 35 条
[1]  
Pluckthun A., Bio/Technology, 9, (1991)
[2]  
Better M., Chang C.P., Robinson R.R., Horwitz A.H., Science, 240, (1988)
[3]  
Skerra A., Pluckthun A., Science, 240, (1988)
[4]  
Horwitz A.H., Chang C.P., Better M., Hellstrom K.E., Robinson R.R., Proc. Natl. Acad. Sci. USA, 85, (1988)
[5]  
Bruggemann M., Neuberger M.S., Prog. Allergy, 45, (1988)
[6]  
Morrison S.L., Oi V.T., Adv. Immunol., 44, (1989)
[7]  
Page M.J., Sydenham M.A., Bio/Technology, 9, (1991)
[8]  
Bebbington C.R., Renner G., Thomson S., King D., Abrahams D., Yarranton G.T., Bio/Technology, 10, (1992)
[9]  
Fouser L.A., Swanberg L., Lin B.W., Benedict M., Kelleher K., Cumming D.A., Riedel G.E., Bio/Technology, 10, (1992)
[10]  
Reff M.E., Curr. Opin. Biotechnol., 4, (1993)